Cargando…
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology Outcomes
SIMPLE SUMMARY: PDE4D5, PDE4D7 and PDE4D9 are prostate expressed transcripts of the PDE4D gene coding for cAMP degrading phosphodiesterases. These genes have been implicated in the change of prostate cancer from an androgen sensitive to an androgen insensitive, treatment resistant state. CAPRA is a...
Autores principales: | Gulliver, Chloe, Huss, Sebastian, Semjonow, Axel, Baillie, George S., Hoffmann, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818961/ https://www.ncbi.nlm.nih.gov/pubmed/36612262 http://dx.doi.org/10.3390/cancers15010262 |
Ejemplares similares
-
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies
por: Gulliver, Chloe, et al.
Publicado: (2023) -
Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region
por: Gulliver, Chloe, et al.
Publicado: (2023) -
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status
por: van Strijp, Dianne, et al.
Publicado: (2019) -
The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
por: van Strijp, Dianne, et al.
Publicado: (2018) -
The enigmatic helicase DHX9 and its association with the hallmarks of cancer
por: Gulliver, Chloe, et al.
Publicado: (2020)